Early brainstem [18F]THK5351 uptake is linked to cortical hyperexcitability in healthy aging.
Aged
Alzheimer Disease
/ diagnostic imaging
Aminopyridines
/ pharmacokinetics
Amyloid beta-Peptides
/ metabolism
Brain Stem
/ diagnostic imaging
Cerebral Cortex
/ pathology
Cross-Sectional Studies
Early Diagnosis
Electroencephalography
Female
Fluorine Radioisotopes
/ pharmacokinetics
Functional Neuroimaging
Healthy Aging
/ metabolism
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Positron-Emission Tomography
Quinolines
/ pharmacokinetics
Radiopharmaceuticals
/ pharmacokinetics
Transcranial Magnetic Stimulation
tau Proteins
/ metabolism
Aging
Alzheimer’s disease
Neuroimaging
Neuroscience
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
25 01 2021
25 01 2021
Historique:
received:
21
07
2020
accepted:
03
12
2020
pubmed:
9
12
2020
medline:
5
6
2021
entrez:
8
12
2020
Statut:
epublish
Résumé
BACKGROUNDNeuronal hyperexcitability characterizes the early stages of Alzheimer's disease (AD). In animals, early misfolded tau and amyloid-β (Aβ) protein accumulation - both central to AD neuropathology - promote cortical excitability and neuronal network dysfunction. In healthy humans, misfolded tau and Aβ aggregates are first detected, respectively, in the brainstem and frontomedial and temporobasal cortices, decades prior to the onset of AD cognitive symptoms. Whether cortical excitability is related to early brainstem tau - and its associated neuroinflammation - and cortical Aβ aggregations remains unknown.METHODSWe probed frontal cortex excitability, using transcranial magnetic stimulation combined with electroencephalography, in a sample of 64 healthy late-middle-aged individuals (50-69 years; 45 women and 19 men). We assessed whole-brain [18F]THK5351 PET uptake as a proxy measure of tau/neuroinflammation, and we assessed whole-brain Aβ burden with [18F]Flutemetamol or [18F]Florbetapir radiotracers.RESULTSWe found that higher [18F]THK5351 uptake in a brainstem monoaminergic compartment was associated with increased cortical excitability (r = 0.29, P = 0.02). By contrast, [18F]THK5351 PET signal in the hippocampal formation, although strongly correlated with brainstem signal in whole-brain voxel-based quantification analyses (P value corrected for family-wise error [PFWE-corrected] < 0.001), was not significantly associated with cortical excitability (r = 0.14, P = 0.25). Importantly, no significant association was found between early Aβ cortical deposits and cortical excitability (r = -0.20, P = 0.11).CONCLUSIONThese findings reveal potential brain substrates for increased cortical excitability in preclinical AD and may constitute functional in vivo correlates of early brainstem tau accumulation and neuroinflammation in humans.TRIAL REGISTRATIONEudraCT 2016-001436-35.FUNDINGF.R.S.-FNRS Belgium, Wallonie-Bruxelles International, ULiège, Fondation Simone et Pierre Clerdent, European Regional Development Fund.
Identifiants
pubmed: 33290274
pii: 142514
doi: 10.1172/jci.insight.142514
pmc: PMC7934880
doi:
pii:
Substances chimiques
Aminopyridines
0
Amyloid beta-Peptides
0
Fluorine Radioisotopes
0
MAPT protein, human
0
Quinolines
0
Radiopharmaceuticals
0
THK5351
0
tau Proteins
0
Banques de données
EudraCT
['2016-001436-35']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Brain. 2016 Feb;139(Pt 2):509-25
pubmed: 26657517
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Neurobiol Aging. 2019 Jun;78:52-63
pubmed: 30877839
Cereb Cortex. 2013 Feb;23(2):332-8
pubmed: 22314045
Neurosci Lett. 2011 Apr 1;492(2):94-8
pubmed: 21281700
Neuroimage Clin. 2013 May 16;2:684-94
pubmed: 24179820
Brain Res. 2019 Jan 1;1702:17-28
pubmed: 29274876
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
J Neurosci. 2013 Jan 23;33(4):1651-9
pubmed: 23345237
Nat Commun. 2016 Jun 24;7:11828
pubmed: 27339884
Biomed J. 2018 Feb;41(1):21-33
pubmed: 29673549
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338
pubmed: 22762015
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Neuroreport. 2011 Aug 24;22(12):592-7
pubmed: 21753711
Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1605-1617
pubmed: 29752516
Neurobiol Aging. 2016 Jan;37:117-126
pubmed: 26521135
J Nucl Med. 2020 Jun;61(6):911-919
pubmed: 31712323
Neuroimage. 2011 Apr 1;55(3):954-67
pubmed: 21216294
Front Aging Neurosci. 2016 Jan 12;7:253
pubmed: 26793103
Acta Neuropathol Commun. 2018 Jun 29;6(1):53
pubmed: 29958546
Nat Neurosci. 2015 Nov;18(11):1584-93
pubmed: 26436904
Acta Neuropathol. 2011 Feb;121(2):171-81
pubmed: 21170538
J Neurosci. 2010 Oct 13;30(41):13707-17
pubmed: 20943911
Curr Opin Neurobiol. 2018 Aug;51:134-138
pubmed: 29753269
Mol Cell Neurosci. 2019 Jun;97:18-33
pubmed: 30529601
PLoS One. 2016 Jun 29;11(6):e0158460
pubmed: 27355840
Alzheimers Dement. 2018 Dec;14(12):1565-1571
pubmed: 30006100
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6058-63
pubmed: 20231476
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1369-1382
pubmed: 30919054
Neuroimage. 2019 Jul 1;194:191-210
pubmed: 30677501
Neurobiol Aging. 2014 Sep;35(9):1982-91
pubmed: 24792906
J Nucl Med. 2018 Apr;59(4):671-674
pubmed: 28864633
EJNMMI Res. 2018 Dec 5;8(1):107
pubmed: 30519791
Prog Neurobiol. 2012 Oct;99(1):42-60
pubmed: 22789698
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Commun Biol. 2019 Dec 3;2:449
pubmed: 31815203
Science. 2019 Feb 22;363(6429):880-884
pubmed: 30679382
Nat Rev Neurosci. 2018 Nov;19(11):687-700
pubmed: 30266970
J Exp Med. 2014 Mar 10;211(3):387-93
pubmed: 24534188
JAMA Neurol. 2014 Aug;71(8):971-7
pubmed: 24887018
J Alzheimers Dis Rep. 2019 May 15;3(1):103-112
pubmed: 31259307
Nat Neurosci. 2010 Jul;13(7):812-8
pubmed: 20581818
Neurology. 2017 Nov 14;89(20):2031-2038
pubmed: 29046362
Nat Neurosci. 2011 Jun;14(6):750-6
pubmed: 21532579
J Neurosci. 2015 Apr 15;35(15):6221-30
pubmed: 25878292
J Neurol. 2010 Dec;257(12):2078-85
pubmed: 20680325
Brain. 2015 Oct;138(Pt 10):2814-33
pubmed: 26283673
Nat Neurosci. 2015 Dec;18(12):1725-7
pubmed: 26551546
Am J Pathol. 2004 Nov;165(5):1643-52
pubmed: 15509534
Science. 2007 May 4;316(5825):750-4
pubmed: 17478722
J Neurosci. 2013 Jul 31;33(31):12887-97
pubmed: 23904623
Mol Neurodegener. 2011 Aug 26;6(1):63
pubmed: 21871088
PLoS Comput Biol. 2017 Sep 22;13(9):e1005707
pubmed: 28938009
Alzheimers Res Ther. 2017 Dec 11;9(1):96
pubmed: 29229003
JAMA Neurol. 2020 Aug 1;77(8):955-965
pubmed: 32391858
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Neurobiol Dis. 2018 Oct;118:161-176
pubmed: 30049665
Brain. 2015 Jun;138(Pt 6):1738-55
pubmed: 25833819
Acta Neuropathol. 2012 Dec;124(6):777-95
pubmed: 22976049
Med Biol Eng Comput. 1999 May;37(3):322-6
pubmed: 10505382
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544
Neuropathol Appl Neurobiol. 2017 Aug;43(5):393-408
pubmed: 28117917